Does canagliflozin improve left ventricular diastolic function in patients with type 2 diabetes?
Canagliflozin may improve left ventricular diastolic function in patients with type 2 diabetes over a short-term period of 3 months.
This study showed for the first time that canagliflozin could improve left ventricular diastolic function within 3 months in patients with T2DM. The benefit was especially apparent in patients with substantially improved hemoglobin values. Trial registration UMIN Clinical Trials Registry UMIN000028141.
Matsutani et al. (2018) studied this question.